AstraZeneca staves off last Tagrisso copycat with settlement—for now

As copycat drugmakers circle the gates, AstraZeneca has won a reprieve for lung cancer cash cow Tagrisso—for now.

AstraZeneca has settled its patent infringement suit with Alembic Pharmaceuticals—the last of three generic holdouts—according to court documents filed Monday.